Bluebird Bio Stock Piotroski F Score

BLUE Stock  USD 3.90  0.06  1.52%   
This module uses fundamental data of Bluebird Bio to approximate its Piotroski F score. Bluebird Bio F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Bluebird bio. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Bluebird Bio financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Bluebird Bio Altman Z Score, Bluebird Bio Correlation, Bluebird Bio Valuation, as well as analyze Bluebird Bio Alpha and Beta and Bluebird Bio Hype Analysis.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
  
At present, Bluebird Bio's Short Term Debt is projected to increase significantly based on the last few years of reporting. The current year's Debt To Equity is expected to grow to 1.60, whereas Short and Long Term Debt Total is forecasted to decline to about 202 M. At present, Bluebird Bio's Days Of Inventory On Hand is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 6.41, whereas PTB Ratio is forecasted to decline to 9.18.
At this time, it appears that Bluebird Bio's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Improving

Focus
Asset Turnover Growth

Decrease

Focus
Current Ratio Change

Decrease

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Decrease

Focus
Change in Gross Margin

No Change

Focus

Bluebird Bio Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Bluebird Bio is to make sure Bluebird is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Bluebird Bio's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Bluebird Bio's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.02820.0429
Way Down
Very volatile
Total Current Liabilities121.9 M230.1 M
Way Down
Slightly volatile
Non Current Liabilities Total167.4 M258.2 M
Way Down
Slightly volatile
Total AssetsB712 M
Way Up
Slightly volatile
Total Current Assets307.7 M323.9 M
Notably Down
Pretty Stable

Bluebird bio F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Bluebird Bio's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Bluebird Bio in a much-optimized way.

About Bluebird Bio Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value Per Share

1.51

At present, Bluebird Bio's Book Value Per Share is projected to slightly decrease based on the last few years of reporting.

Bluebird Bio ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bluebird Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bluebird Bio's managers, analysts, and investors.
Environmental
Governance
Social

About Bluebird Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bluebird bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bluebird Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bluebird bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:
Check out Bluebird Bio Altman Z Score, Bluebird Bio Correlation, Bluebird Bio Valuation, as well as analyze Bluebird Bio Alpha and Beta and Bluebird Bio Hype Analysis.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(36.00)
Revenue Per Share
6.077
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.37)
Return On Equity
(2.70)
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.